Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Natural Killer Cells”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT03736330
What this trial is testing

Anti-PD-1 Combinations of D-CIK Immunotherapy and Axitinib in Advanced Ranal Carcinoma

Who this might be right for
Renal Cancer Metastatic
Sun Yat-sen University 24
Not applicableLooking for participantsNCT06885476
What this trial is testing

Infusion of Alloreactive nk Cells for Mrd-positive Aml Patients

Who this might be right for
Acute Myeloid LeukemiaMinimal Residual DiseaseNatural Killer Cell
IRCCS Azienda Ospedaliero-Universitaria di Bologna 22
Not applicableActive Not RecruitingNCT05315388
What this trial is testing

Effects of "Vitamin N" Nature Immersion Therapy on Stress Levels in Health Care Workers in the City of Bogotá

Who this might be right for
Cortisol ExcessStress, PsychologicalAnxiety+3 more
Jeadran N. Malagón-Rojas 118
Testing effectiveness (Phase 2)Study completedNCT02118415
What this trial is testing

Targeted Natural Killer (NK) Cell Based Adoptive Immunotherapy for the Treatment of Patients With Non-Small Cell Lung Cancer (NSCLC) After Radiochemotherapy (RCT)

Who this might be right for
NSCLC Stage IIIA/B
Technical University of Munich 13
Testing effectiveness (Phase 2)Looking for participantsNCT06687681
What this trial is testing

Injection of Active Allogeneic Natural Killer Cells in Patients With Gliomas

Who this might be right for
Glioma Glioblastoma MultiformeHigh Grade Glioma (III or IV)
Marzieh Ebrahimi 40
Not applicableStudy completedNCT02525250
What this trial is testing

Pilot Study Immunomonitoring Natural Killers Cells in Patients With Myeloid Malignancies Treated With Lenalidomide

Who this might be right for
Acute Myeloid Leukemia or Myelodysplasic Syndrome
Institut Paoli-Calmettes 14
Not applicableStudy completedNCT02884557
What this trial is testing

NKT Role in the Regulation of the Inflammatory Bowel Disease

Who this might be right for
Inflammatory Bowel DiseasesPrimary Sclerosing Cholangitis
University Hospital, Lille 64
Not applicableStudy completedNCT00341809
What this trial is testing

Genetic Analysis of Psoriasis and Psoriatic Arthritis

Who this might be right for
Psoriasis
National Cancer Institute (NCI) 2,653
Large-scale testing (Phase 3)Looking for participantsNCT03902912
What this trial is testing

Effect of Prednisolone Treatment on Uterine Natural Killer Cells

Who this might be right for
Recurrent Miscarriage
Chinese University of Hong Kong 84
Early research (Phase 1)Ended earlyNCT04310592
What this trial is testing

Natural Killer Cell (CYNK-001) Infusions in Adults with AML

Who this might be right for
LeukemiaLeukemia, MyeloidLeukemia, Myeloid, Acute+17 more
Celularity Incorporated 27
Large-scale testing (Phase 3)WithdrawnNCT07492875
What this trial is testing

Study of Nogapendekin Alfa Inbakicept and iNKT Cells in Critically Ill Adults With Severe Community-Acquired Pneumonia

Who this might be right for
Community-Acquired Pneumonia (CAP)Acute Respiratory Distress Syndrome (ARDS)Sepsis+2 more
ImmunityBio, Inc.
Early research (Phase 1)Study completedNCT00900809
What this trial is testing

QUILT-3.018: Neukoplast™ (NK-92) for the Treatment of Refractory or Relapsed Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia
ImmunityBio, Inc. 7
Early research (Phase 1)Ended earlyNCT05601830
What this trial is testing

Natural Killer(NK) Cell Therapy for AML Minimal Residual Disease

Who this might be right for
Minimal Residual Disease
Institute of Hematology & Blood Diseases Hospital, China 1
Testing effectiveness (Phase 2)Study completedNCT00303667
What this trial is testing

Donor Natural Killer Cells and Aldesleukin in Treating Patients w/High Risk AML Undergoing Donor Stem Cell Transplant

Who this might be right for
Acute Myelogenous Leukemia
Masonic Cancer Center, University of Minnesota 50
Early research (Phase 1)Study completedNCT03346499
What this trial is testing

Adoptive Transfer of Haploidentical Natural Killer Cells and IL-2

Who this might be right for
HIV
University of Minnesota 4
Early research (Phase 1)Ended earlyNCT05601466
What this trial is testing

Natural Killer(NK) Cell Therapy for Acute Myeloid Leukemia

Who this might be right for
AML, Adult
Institute of Hematology & Blood Diseases Hospital, China 3
Large-scale testing (Phase 3)Study completedNCT00412360
What this trial is testing

Single vs Double Umbilical Cord Blood Transplants in Children With High Risk Leukemia and Myelodysplasia (BMT CTN 0501)

Who this might be right for
Acute Myelogenous LeukemiaAcute Lymphocytic LeukemiaChronic Myelogenous Leukemia+2 more
Medical College of Wisconsin 224
Early research (Phase 1)Temporarily pausedNCT05887882
What this trial is testing

Intra-Tumoral Injections of Natural Killer Cells for Recurrent Malignant Pediatric Brain Tumors

Who this might be right for
Pediatric Brain TumorRecurrent Pediatric Brain TumorPediatric Neoplasm
Sabine Mueller, MD, PhD 24
Early research (Phase 1)Looking for participantsNCT06631391
What this trial is testing

Phase I Study of Umbilical Cord Blood Natural Killer (NK) Cell Therapy for Children With High-risk, R/R Neuroblastoma.

Who this might be right for
Neuroblastoma
Sun Yat-sen University 30
Early research (Phase 1)Study completedNCT05108623
What this trial is testing

A Study Investigating agenT-797 in Participants With Relapsed/Refractory Solid Tumors

Who this might be right for
Tumor, Solid
MiNK Therapeutics 34
Next Page